Literature DB >> 22137430

Animal models of muscular dystrophy.

Rainer Ng1, Glen B Banks, John K Hall, Lindsey A Muir, Julian N Ramos, Jacqueline Wicki, Guy L Odom, Patryk Konieczny, Jane Seto, Joel R Chamberlain, Jeffrey S Chamberlain.   

Abstract

The muscular dystrophies (MDs) represent a diverse collection of inherited human disorders, which affect to varying degrees skeletal, cardiac, and sometimes smooth muscle (Emery, 2002). To date, more than 50 different genes have been implicated as causing one or more types of MD (Bansal et al., 2003). In many cases, invaluable insights into disease mechanisms, structure and function of gene products, and approaches for therapeutic interventions have benefited from the study of animal models of the different MDs (Arnett et al., 2009). The large number of genes that are associated with MD and the tremendous number of animal models that have been developed preclude a complete discussion of each in the context of this review. However, we summarize here a number of the more commonly used models together with a mixture of different types of gene and MD, which serves to give a general overview of the value of animal models of MD for research and therapeutic development.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22137430      PMCID: PMC4872622          DOI: 10.1016/B978-0-12-394596-9.00004-4

Source DB:  PubMed          Journal:  Prog Mol Biol Transl Sci        ISSN: 1877-1173            Impact factor:   3.622


  193 in total

1.  Skeletal muscle-specific expression of a utrophin transgene rescues utrophin-dystrophin deficient mice.

Authors:  J A Rafael; J M Tinsley; A C Potter; A E Deconinck; K E Davies
Journal:  Nat Genet       Date:  1998-05       Impact factor: 38.330

2.  Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy.

Authors:  J W Miller; C R Urbinati; P Teng-Umnuay; M G Stenberg; B J Byrne; C A Thornton; M S Swanson
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

3.  Removal of the calpain 3 protease reverses the myopathology in a mouse model for titinopathies.

Authors:  Karine Charton; Nathalie Danièle; Anna Vihola; Carinne Roudaut; Evelyne Gicquel; François Monjaret; Anne Tarrade; Jaakko Sarparanta; Bjarne Udd; Isabelle Richard
Journal:  Hum Mol Genet       Date:  2010-09-20       Impact factor: 6.150

4.  Muscle development in mdx mutant mice.

Authors:  J Dangain; G Vrbova
Journal:  Muscle Nerve       Date:  1984 Nov-Dec       Impact factor: 3.217

5.  Calpain 3 is a modulator of the dysferlin protein complex in skeletal muscle.

Authors:  Yanchao Huang; Antoine de Morrée; Alexandra van Remoortere; Kate Bushby; Rune R Frants; Johan T den Dunnen; Silvère M van der Maarel
Journal:  Hum Mol Genet       Date:  2008-03-11       Impact factor: 6.150

6.  Molecular pathogenesis of severe cardiomyopathy in the TO-2 hamster.

Authors:  Aiji Sakamoto
Journal:  Exp Clin Cardiol       Date:  2003

Review 7.  Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations.

Authors:  Annemieke Aartsma-Rus; Ivo Fokkema; Jan Verschuuren; Ieke Ginjaar; Judith van Deutekom; Gert-Jan van Ommen; Johan T den Dunnen
Journal:  Hum Mutat       Date:  2009-03       Impact factor: 4.878

8.  Structure of recombinant N-terminal globule of type VI collagen alpha 3 chain and its binding to heparin and hyaluronan.

Authors:  U Specks; U Mayer; R Nischt; T Spissinger; K Mann; R Timpl; J Engel; M L Chu
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

9.  Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues.

Authors:  K L Taneja; M McCurrach; M Schalling; D Housman; R H Singer
Journal:  J Cell Biol       Date:  1995-03       Impact factor: 10.539

10.  Progressive muscular dystrophy in alpha-sarcoglycan-deficient mice.

Authors:  F Duclos; V Straub; S A Moore; D P Venzke; R F Hrstka; R H Crosbie; M Durbeej; C S Lebakken; A J Ettinger; J van der Meulen; K H Holt; L E Lim; J R Sanes; B L Davidson; J A Faulkner; R Williamson; K P Campbell
Journal:  J Cell Biol       Date:  1998-09-21       Impact factor: 10.539

View more
  22 in total

1.  Removing the immune response from muscular dystrophy research.

Authors:  Jeffrey S Chamberlain
Journal:  Mol Ther       Date:  2013-10       Impact factor: 11.454

Review 2.  A human-on-a-chip approach to tackling rare diseases.

Authors:  Camilly P Pires de Mello; John Rumsey; Victoria Slaughter; James J Hickman
Journal:  Drug Discov Today       Date:  2019-08-11       Impact factor: 7.851

3.  α-Ketoglutarate prevents skeletal muscle protein degradation and muscle atrophy through PHD3/ADRB2 pathway.

Authors:  Xingcai Cai; Yexian Yuan; Zhengrui Liao; Kongping Xing; Canjun Zhu; Yaqiong Xu; Lulu Yu; Lina Wang; Songbo Wang; Xiaotong Zhu; Ping Gao; Yongliang Zhang; Qingyan Jiang; Pingwen Xu; Gang Shu
Journal:  FASEB J       Date:  2017-09-22       Impact factor: 5.191

Review 4.  Recent advances using zebrafish animal models for muscle disease drug discovery.

Authors:  Lisa Maves
Journal:  Expert Opin Drug Discov       Date:  2014-06-14       Impact factor: 6.098

Review 5.  Absence of Dystrophin Disrupts Skeletal Muscle Signaling: Roles of Ca2+, Reactive Oxygen Species, and Nitric Oxide in the Development of Muscular Dystrophy.

Authors:  David G Allen; Nicholas P Whitehead; Stanley C Froehner
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

6.  Mitochondrial alterations and oxidative stress in an acute transient mouse model of muscle degeneration: implications for muscular dystrophy and related muscle pathologies.

Authors:  Renjini Ramadasan-Nair; Narayanappa Gayathri; Sudha Mishra; Balaraju Sunitha; Rajeswara Babu Mythri; Atchayaram Nalini; Yashwanth Subbannayya; Hindalahalli Chandregowda Harsha; Ullas Kolthur-Seetharam; Muchukunte Mukunda Srinivas Bharath
Journal:  J Biol Chem       Date:  2013-11-12       Impact factor: 5.157

7.  Simultaneous Pathoproteomic Evaluation of the Dystrophin-Glycoprotein Complex and Secondary Changes in the mdx-4cv Mouse Model of Duchenne Muscular Dystrophy.

Authors:  Sandra Murphy; Michael Henry; Paula Meleady; Margit Zweyer; Rustam R Mundegar; Dieter Swandulla; Kay Ohlendieck
Journal:  Biology (Basel)       Date:  2015-06-10

8.  Genetic silencing of Nrf2 enhances X-ROS in dysferlin-deficient muscle.

Authors:  Ponvijay Kombairaju; Jaclyn P Kerr; Joseph A Roche; Stephen J P Pratt; Richard M Lovering; Thomas E Sussan; Jung-Hyun Kim; Guoli Shi; Shyam Biswal; Christopher W Ward
Journal:  Front Physiol       Date:  2014-02-19       Impact factor: 4.566

9.  Altered Tnnt3 characterizes selective weakness of fast fibers in mice overexpressing FSHD region gene 1 (FRG1).

Authors:  Valentina Sancisi; Elena Germinario; Alessandra Esposito; Elisabetta Morini; Samantha Peron; Maurizio Moggio; Giuliano Tomelleri; Daniela Danieli-Betto; Rossella Tupler
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-12-04       Impact factor: 3.619

10.  Application of fluorescence two-dimensional difference in-gel electrophoresis as a proteomic biomarker discovery tool in muscular dystrophy research.

Authors:  Steven Carberry; Margit Zweyer; Dieter Swandulla; Kay Ohlendieck
Journal:  Biology (Basel)       Date:  2013-12-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.